Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative-Reference-Cited by-同舟云学术

Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative

Published:2022-01 Issue:1 Volume:4 Page:e33-e41
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Andersen Kathleen M,Bates Benjamin A,Rashidi Emaan S,Olex Amy L,Mannon Roslyn B,Patel Rena C,Singh Jasvinder,Sun Jing,Auwaerter Paul G,Ng Derek K,Segal Jodi B,Garibaldi Brian T,Mehta Hemalkumar B,Alexander G Caleb,Haendel Melissa A,Chute Christopher G

Funder

National Heart Lung and Blood Institute

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference30 articles.

1. Coronavirus disease 2019 (COVID-19) and transplantation: pharmacotherapeutic management of immunosuppression regimen;Mirjalili;Ther Clin Risk Manag,2020

2. Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic;Serling-Boyd;Ann Rheum Dis,2021

3. Risk of COVID-19 in rheumatoid arthritis: a national veterans affairs matched cohort study in at-risk individuals;England;Arthritis Rheumatol,2021

4. COVID-19 Outcomes in patients with systemic autoimmune rheumatic diseases compared to the general population: a US multicenter, comparative cohort study;D'Silva;Arthritis Rheumatol,2021

5. Characteristics and outcomes of recipients of heart transplant with coronavirus disease 2019;Latif;JAMA Cardiol,2020

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence, risk factors and characterisation of individuals with long COVID using Electronic Health Records in over 1.5 million COVID cases in England;Journal of Infection;2024-10

2. COVID-19 in patients with interstitial lung disease;COVID-19: An Update;2024-09-01

3. COVID-19 in the immunocompromised host;COVID-19: An Update;2024-09-01

4. Effect of cyclosporin A on respiratory viral replication in fully differentiated ex vivo human airway epithelia;Pharmacology Research & Perspectives;2024-08-29

5. Do rheumatic diseases, long‐term glucocorticoids, and immunosuppressant treatment, and vaccination impact the COVID‐19 severity? Insight from a retrospective cohort study;International Journal of Rheumatic Diseases;2024-07